Low Back Pain Flashcards
What is the definition of lower back pain?
- pain between bottom of the ribs and the top of the legs
Lower back pain is defined as pain between the bottom of the ribs and the top of the legs. What is the definition of acute (A), sub-acute (SA) and chronic (C) lower back pain?
1 - A = <6 weeks, SA = 6-24 weeks, C = >24 weeks
2 - A = <4 weeks, SA = 4-16 weeks, C = >16 weeks
3 - A = <6 weeks, SA = 6-12 weeks, C = >12 weeks
4 - A = <2 weeks, SA = 2-12 weeks, C = >12 weeks
3 - A = <6 weeks, SA = 6-12 weeks, C = >12 weeks
What is the definition of mechanical back pain?
- joints, discs, muscles and connective tissue make up mechanics
- mechanical pain is when the mechanics are impaired causing pain
In addition to mechanical pain, the GP must rule out what 2 other causes of back pain?
- nerve root pain
- spinal pathology (malignancy, infection, fracture, inflammation)
Ankylosing spondyilitis can be broken down into the following:
- ankylosing = stiffness
- spondy = spine
- itis = inflammation
What is ankylosing spondyilitis?
- autoimmune disorder causing inflammation of the spinal joints
Ankylosing spondyilitis can be broken down into the following:
- ankylosing = stiffness
- spondy = spine
- itis = inflammation
Ankylosing spondyilitis is an autoimmune disorder causing inflammation of the spinal joints. What 2 joints of the spine are commonly affected?
- facet joints
- intervertebral discs
Ankylosing spondyilitis can be broken down into the following:
- ankylosing = stiffness
- spondy = spine
- itis = inflammation
Ankylosing spondyilitis is an autoimmune disorder causing inflammation of the spinal joints, specifically the facet joints and the intervertebral discs. In humans we have genes on chromosome 6 that encode the human leukocyte antigen (HLA) which identify self cells that MHC-1 molecules can bind with to identify cells are our own. However, patients with ankylosing spondylitis commonly have the same HLA gene that has been linked with ankylosing spondyilitis. What gene is this?
1 - HLA-A1
2 - HLA-A27
3 - HLA-B1
4 - HLA-B27
4 - HLA-B27
- cytotoxic CD8 cells bind to the MHC-1 encoded by HLA-B27 and cause immune response
In a patient with lower back pain, what are 5 key red flag symptoms?
- night pain keeping patient awake
- loss of bowel and urinary control (could be cauda aquina)
- numbness around back passage (could be cauda aquina)
- fever and weight loss
- thoracic pain
In a patient with lower back pain, 2 red flag symptoms are loss of bowel and urinary control and numbness around the back passage. What are 2 important diagnosis that must not be missed in a patient with the red flag symptoms that are dangerous?
- cauda equina syndrome
- cancer
Saddle anaesthesia refers to reduced sensation in the area that would be in contact with a saddle if sitting on one. What is a common cause of this?
1 - fragility fracture
2 - nerve root pain
3 - malignancy
4 - fractured coccyx
2 - nerve root pain
If a patient presents with lower back pain, is imaging generally useful?
- no
- generally does not identify cause
What does the mnemonic SOCRATES stand for?
- S = site of pain
- O = onset of pain
- C = character of pain (sharp or dull)
- R = radiates
- A = associated features of the pain
- T = timing of pain
- E = exacerbating and relieving factors
- S = severity of pain
If a patient has previously had cancer and is in remission, but is now experiencing back pain, what could be the cause of the back pain?
- metastatic and cancer of the vertebrae
If we perform blood tests in a patient with lower back pain, what are we likely to measure?
- inflammatory markers
What blood markers would suggest malignancy if they were raised in a patient with back pain?
1 - Ca2+, alkaline phosphatase, creatine kinase
2 - alkaline phosphatase, creatine kinase, prostate specific antigen
3 - alkaline phosphatase, Ca2+, prostate specific antigen
4 - Ca2+, prostate specific antigen and creatine kinase
3 - alkaline phosphatase (ALP), Ca2+, prostate specific antigen (PSA)
- ALP and Ca2+ would suggest tumour degrading bone
- PSA would suggest primary malignancy site